Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.55 |
| ▸ | AKT1 | P31749 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | BCHE | P06276 | 3/20 | 0.53 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.53 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.53 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.48 |
| ▸ | RELA | Q04206 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11028515 | 1.00 | RECQL (0.55) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL2038400 | 0.80 | ALDH1A1 (0.41) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL2954324 | 0.79 | MAPT (0.70) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL11073619 | 0.79 | MAPT (0.70) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL2954318 | 0.79 | MAPT (0.70) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL28355230 | 0.79 | AKT1 (0.54) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL26959426 | 0.79 | AKT1 (0.54) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL11238958 | 0.79 | MAOB (0.59) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL11008184 | 0.78 | ALDH1A1 (0.54) | RECQLAKT1MAPTLMNABCHE | |
| SCHEMBL16306951 | 0.78 | AKT1 (0.48) | RECQLAKT1MAPTLMNABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773114-B2 | Protective groups and methods for protecting benzoxaboroles or oxaboroles | SAINT JOSEPH'S UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| US-11773114-B2 | Protective groups and methods for protecting benzoxaboroles or oxaboroles | SAINT JOSEPH'S UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| US-20200407375-A1 | PROTECTIVE GROUPS AND METHODS FOR PROTECTING BENZOXABOROLES OR OXABOROLES | UNIVERSITY OF THE SCIENCES (US) | 2020-12-31 | — | — | US | disclosed |
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2012-02-02 | — | — | US | disclosed |
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2012-02-02 | — | — | US | disclosed |
| WO-2010066450-A1 | A METHOD FOR PREPARING SULFUR-CONTAINING COMPOUNDS | THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2010-06-17 | — | — | WO | disclosed |
| US-20100041746-A1 | NOVEL USE OF ORGANIC COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2010-02-18 | — | — | US | disclosed |
| EP-0071165-B1 | UNSATURATED ARYL KETONES AS ANTISEBORRHOEIC ADDITIVES FOR COSMETIC COMPOSITIONS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1985-09-04 | — | — | EP | disclosed |
| US-4439418-A | UNSATURATED ARYL KETONE | HENKEL KGAA (DE) | 1984-03-27 | — | — | US | disclosed |
| EP-0071165-A1 | Unsaturated aryl ketones as antiseborrhoeic additives for cosmetic compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 1983-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029197-A1 | Method for Preparing Sulfur-Containing Compounds | SULT1E1, SULT1A1, TST | RECQL 4797/4885AKT1 3046/4885MAPT 4581/4885 |
| US-11773114-B2 | Protective groups and methods for protecting benzoxaboroles or oxaboroles | TXN2, ABCB7, TXN | RECQL 908/4885AKT1 4754/4885MAPT 4567/4885 |
| US-20200407375-A1 | PROTECTIVE GROUPS AND METHODS FOR PROTECTING BENZOXABOROLES OR OXABOROLES | ABCB7, TXN2, PRDX3 | RECQL 886/4885AKT1 4708/4885MAPT 4611/4885 |
| US-20100041746-A1 | NOVEL USE OF ORGANIC COMPOUNDS | FABP2, FABP4, CPT1B | RECQL 4234/4885AKT1 2474/4885MAPT 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.